Changeflow GovPing Pharma & Drug Safety EPO Patent Publication EP4048683A2: Variant Alp...
Routine Notice Added Final

EPO Patent Publication EP4048683A2: Variant Alpha-Amylases

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Peptides (C07K)
Published March 11th, 2026
Detected March 26th, 2026
Email

Summary

The European Patent Office has published patent application EP4048683A2 concerning variant maltopentaose/maltohexaose-forming alpha-amylases, with Danisco US Inc. listed as the applicant. This publication is part of the EPO's regular bulletin for the C07K classification, related to peptides.

What changed

The European Patent Office (EPO) has published patent application EP4048683A2, titled 'Variant maltopentaose/maltohexaose-forming alpha-amylases'. The application was filed by Danisco US Inc. and lists several inventors. This publication is part of the EPO's bulletin for the C07K classification, which pertains to peptides.

This is a patent publication, not a regulatory rule or enforcement action. It does not impose new compliance obligations or deadlines on regulated entities. Companies operating in the biotechnology or pharmaceutical sectors may wish to review the patent details for competitive intelligence or potential licensing opportunities. The designated states indicate broad European coverage for this patent application.

Source document (simplified)

← EPO Patent Bulletin

VARIANT MALTOPENTAOSE/MALTOHEXAOSE-FORMING ALPHA-AMYLASES

Publication EP4048683A2 Kind: A2 Mar 11, 2026

Applicants

Danisco US Inc

Inventors

BHATE, Manasi, CHAN, Hon Kit, LASSILA, Jonathan, PAUL, Brian James, RAMER, Sandra W., TRAN, Patricia

IPC Classifications

C07K 14/415 20060101AFI20210430BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

VARIANT MALTOPENTAOSE/MALTOHEXAOSE-FORMING ALPHA-AMYLASES

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 11th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP4048683A2

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Drug Labeling
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Biotechnology Intellectual Property

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Peptides (C07K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.